Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

The Grb2-mSos1 complex binds phosphopeptides with higher affinity than Grb2.

Chook YM, Gish GD, Kay CM, Pai EF, Pawson T.

J Biol Chem. 1996 Nov 29;271(48):30472-8. Erratum in: J Biol Chem 1997 Feb 7;272(6):3870.

2.

MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes.

Rozakis-Adcock M, van der Geer P, Mbamalu G, Pawson T.

Oncogene. 1995 Oct 5;11(7):1417-26.

PMID:
7478566
3.

Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2.

Lemmon MA, Ladbury JE, Mandiyan V, Zhou M, Schlessinger J.

J Biol Chem. 1994 Dec 16;269(50):31653-8.

4.

The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.

Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D.

Nature. 1993 May 6;363(6424):83-5.

PMID:
8479540
6.

Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor.

Batzer AG, Rotin D, UreƱa JM, Skolnik EY, Schlessinger J.

Mol Cell Biol. 1994 Aug;14(8):5192-201.

7.

Interaction of Shc with Grb2 regulates association of Grb2 with mSOS.

Ravichandran KS, Lorenz U, Shoelson SE, Burakoff SJ.

Mol Cell Biol. 1995 Feb;15(2):593-600.

8.

Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.

Sasaoka T, Langlois WJ, Bai F, Rose DW, Leitner JW, Decker SJ, Saltiel A, Gill GN, Kobayashi M, Draznin B, Olefsky JM.

J Biol Chem. 1996 Apr 5;271(14):8338-44.

9.
10.

Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.

Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A.

J Mol Biol. 2002 Feb 1;315(5):1167-77.

PMID:
11827484
12.

The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells.

Kon-Kozlowski M, Pani G, Pawson T, Siminovitch KA.

J Biol Chem. 1996 Feb 16;271(7):3856-62.

13.

Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.

Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R, Pawson T.

EMBO J. 1994 Feb 15;13(4):764-73.

14.

The signaling pathway coupling epidermal growth factor receptors to activation of p21ras.

Sasaoka T, Langlois WJ, Leitner JW, Draznin B, Olefsky JM.

J Biol Chem. 1994 Dec 23;269(51):32621-5.

15.

Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.

Xu XX, Yi T, Tang B, Lambeth JD.

Oncogene. 1998 Mar 26;16(12):1561-9.

16.
17.

The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.

Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R, Myers MJ Jr, Backer JM, Ullrich A, White MF, et al.

EMBO J. 1993 May;12(5):1929-36.

18.

A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase.

Li W, Nishimura R, Kashishian A, Batzer AG, Kim WJ, Cooper JA, Schlessinger J.

Mol Cell Biol. 1994 Jan;14(1):509-17.

19.
20.

Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.

Ricci A, Lanfrancone L, Chiari R, Belardo G, Pertica C, Natali PG, Pelicci PG, Segatto O.

Oncogene. 1995 Oct 19;11(8):1519-29.

PMID:
7478576
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk